<code id='79DAD15B05'></code><style id='79DAD15B05'></style>
      • <acronym id='79DAD15B05'></acronym>
      <center id='79DAD15B05'><center id='79DAD15B05'><tfoot id='79DAD15B05'></tfoot></center><abbr id='79DAD15B05'><dir id='79DAD15B05'><tfoot id='79DAD15B05'></tfoot><noframes id='79DAD15B05'>
      • <optgroup id='79DAD15B05'><strike id='79DAD15B05'><sup id='79DAD15B05'></sup></strike><code id='79DAD15B05'></code></optgroup>
        5. <b id='79DAD15B05'><label id='79DAD15B05'><select id='79DAD15B05'><dt id='79DAD15B05'><span id='79DAD15B05'></span></dt></select></label></b><u id='79DAD15B05'></u>
          <i id='79DAD15B05'><strike id='79DAD15B05'><tt id='79DAD15B05'><pre id='79DAD15B05'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-08-03 05:58:01 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：5953
                                  
                                    
          
                                   
          AI skin cancer detector, dermasensor. -- health tech coverage from STAT
          Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early.																									Courtesy DermaSensor
          The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.
          Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.
          advertisement
          The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Doulas covered by Medicaid under New York's new plan
                                
                            
          Next article：  
                                      
                                          Peter Hotez and the public health issue of online harassment
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles